This application corresponds to my German Patent application No. P 31 28 018.8, filed on July 13, 1981 which is relied upon and incorporated by reference herein.
FIELD OF THE INVENTION
The invention is directed to a method for diagnosing and for therapeutic treatment of tumors and infectious
FIELD OF THE INVENTION
This invention involves means for treating neuronal injury and achieving analgesia by administration of compositions containing compounds of the formula: ##STR2## wherein R.sup.1 and R.sup.2 are alkyl having 1-8 carbon atoms.
BACKGROUND OF THE INVENTION
Compounds having an
FIELD OF THE INVENTION
This invention involves means for treating neuronal injury and achieving analgesia by administration of compositions containing compounds of the formula: ##STR2##
wherein R.sup.1 and R.sup.2 are alkyl having 1-8 carbon atoms.
BACKGROUND OF THE INVENTION
Compounds having an
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
None
BACKGROUND OF THE INVENTION
The invention relates to the prevention and treatment of cancers in animals. More specifically the invention relates to the use of metal chelating materials including, picolinic acid, fusaric acid and
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a National Stage of PCT/JP09/001770 filed Apr. 17, 2009 and claims the benefit of JP 2008-108754 filed Apr. 18, 2008.
TECHNICAL FIELD
The present invention relates to an iontophoretic preparation for treatment of breast cancer and/or
FIELD OF THE INVENTION
The invention relates to chemical compounds and pharmaceutical compositions, including novel chemical compounds and pharmaceutical compositions thereof, useful in the treatment of various diseases and disease states. The invention also relates to methods of synthesizing
FIELD OF THE INVENTION
The invention relates to chemical compounds and pharmaceutical compositions, including novel chemical compounds and pharmaceutical compositions thereof, useful in the treatment of various diseases and disease states. The invention also relates to methods of synthesizing
TECHNICAL FIELD
The present invention belongs to the field of chemical pharmaceuticals, particularly relates to coupling compounds of NSAID anti-inflammatory and analgesic drugs and EGFR inhibitors or pharmaceutically acceptable salts or stereoisomers thereof and prodrug molecules thereof, synthesis
This application is a .sctn.371 national stage of PCT International Application No. PCT/PL2008/000020, filed Mar. 7, 2008, and claims priority of Polish Patent Application No. P.381925, filed Mar. 7, 2007, the contents of all of which are hereby incorporated by reference into this application.
BRIEF
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a protein composition of matter and a method for the treatment of chronic pain, especially to the treatment of heretofore intractable pain as associated with advanced cancer. The pain associated with neurological
FIELD OF THE INVENTION
The present invention relates to the field of cancer prevention. Specifically, compositions and methods for slowing and/or inhibiting Barrett's esophagus progression to its associated adenocarcinoma are disclosed.
BACKGROUND OF THE INVENTION
Several publications and patent
BACKGROUND OF THE INVENTION
This invention relates to sulfonyl heteroaryl triazoles, methods of treatment and pharmaceutical compositions for the treatment of cyclooxygenase mediated diseases.
Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used in treating pain and the signs and symptoms
BACKGROUND OF THE INVENTION
This invention relates to sulfonyl heteroaryl triazoles, methods of treatment and pharmaceutical compositions for the treatment of cyclooxygenase mediated diseases.
Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used in treating pain and the signs and symptoms
This application is a national stage U.S. application filed under 35 U.S.C. 371 of International application PCT/JP03/00350, filed Jan. 17, 2003, which claimed the priority of Japanese Patent 2002-11914 filed Jan. 21, 2002, the disclosures of which are incorporated herein in its entirety by
BACKGROUND
.DELTA..sup.9 -Tetrahydrocannabinol, the pyschoactive marijuana derived cannabinoid, binds to the CB1 receptor in the brain and to the CB2 receptor in the spleen. Compounds which stimulate the CB1 receptor have been shown to induce analgesia and sedation, to cause mood elevation, to
Den mest komplette databasen med medisinske urter støttet av vitenskap
Fungerer på 55 språk
Urtekurer støttet av vitenskap
Urtegjenkjenning etter bilde
Interaktivt GPS-kart - merk urter på stedet (kommer snart)
Les vitenskapelige publikasjoner relatert til søket ditt
Søk medisinske urter etter deres effekter
Organiser dine interesser og hold deg oppdatert med nyheter, kliniske studier og patenter
Skriv inn et symptom eller en sykdom og les om urter som kan hjelpe, skriv en urt og se sykdommer og symptomer den brukes mot. * All informasjon er basert på publisert vitenskapelig forskning